You just read:

For the Treatment of Rheumatoid Arthritis, Surveyed European Rheumatologists Expect Well-Established TNF-Alpha Inhibitors to Lose Considerable Patient Share to Newer Agents in This Drug Class

News provided by

Decision Resources

Oct 14, 2010, 09:00 ET